Annual Report 2019

Department of Intensive Care Medicine

Ryohei Serita

Introduction

 The Department of Intensive Care Medicine came into existence on November 1, 2016.

 The mission of our department is to provide safe and efficient care for postoperative patients and critically ill patients. In step with the aging of the population, patients with cancer have been at higher risk of complications at the pretreatment evaluation. Therefore, high-quality care is needed to ensure efficient procedures. We believe that the new department plays a pivotal role in safe and efficient care for patients within the National Cancer Center Hospital East. We are working with the aim to further enhance such care.

The Team and What We Do

 Our clinical focus is to manage the eight-bed intensive care unit (ICU) and provide specialist advice to the attending physicians for all critically ill patients. The number of patients admitted to the ICU was 1,640 in 2019 and increased by about 4% from the previous year (Table 1). Since the facility standards were met, intensive care addition was also calculated from Sep 2019.

Table 1. Number of patients admitted to ICU (Apr 2019 - Mar 2020)

Research activities

 Our research interests include magnesium ion homeostasis of cancer patients. Several studies have been in the planning stage.

Clinical trials

 Currently, the department has no clinical trials.

Education

 Currently, our department has no educational programs for residents.

Future prospects

 The objective of our department is to establish an ICU that has a functional role in offering highly intensive care for the cancer patients. We will work to further define and refine what we do in providing high-quality care.